Shopping Cart (0)
My Account

Shopping Cart
SELECTBIO Conferences Point-of-Care, Biosensors & Mobile Diagnostics Europe 2021

Martyn Boutelle's Biography



Martyn Boutelle, Professor of Biomedical Sensors Engineering, Imperial College London

Martyn Boutelle is Professor of Biomedical Sensors Engineering in the Department of Bioengineering, Imperial College London, and Associate Provost for Estates Planning for Imperial College.
His research group is multidisciplinary comprising, bioengineers, scientists, and clinicians. He develops novel analytical science methods using microfluidics, electrochemical sensors / biosensors, and wireless electronics to make portable (sometimes wearable) monitoring devices for use as point of care devices that typically giving continuous real -time displays. He then uses these in a program of clinical science research focusing on the acute traumatic brain injury including that caused by cardiac arrest, neonatal continuous monitoring and kidney transplantation monitoring. He runs the EPSRC funded Bio-nanofabrication suite designed to make microfluidic and biosensor biosensors using scalable methods to allow use in proof-of-concept clinical trials.

Martyn is past president of the International Society for Monitoring Molecules in Neuroscience, and a founder of the COSBID organization for studying acute human brain injury. He published > 190 papers, chapters and patents. He obtained a BSc and PhD in Chemistry from Imperial College and worked as an EP Abraham Research Fellow in the University of Oxford.

Martyn Boutelle Image

Novel Microfluidic Approaches to Real-Time Tissue Monitoring

Wednesday, 30 June 2021 at 14:00

Add to Calendar ▼2021-06-30 14:00:002021-06-30 15:00:00Europe/LondonNovel Microfluidic Approaches to Real-Time Tissue MonitoringPoint-of-Care, Biosensors and Mobile Diagnostics Europe 2021 in Rotterdam, The NetherlandsRotterdam, The NetherlandsSELECTBIOenquiries@selectbiosciences.com

The idea of making decisions, using for example AI, based on an information stream is influencing all aspects of life. In Healthcare this is emerging as the personalization of healthcare – where data is used to track the progression of illness and the effects of treatment in a patient at the individual level, rather than using the population average. To do this using biomolecular information requires combinations of microfluidic devices, sensors and electronics designed to embed analytical best practice. I will present recent work on new types of microfluidic devices for monitoring human tissue and the brain.


Add to Calendar ▼2021-06-28 00:00:002021-06-30 00:00:00Europe/LondonPoint-of-Care, Biosensors and Mobile Diagnostics Europe 2021Point-of-Care, Biosensors and Mobile Diagnostics Europe 2021 in Rotterdam, The NetherlandsRotterdam, The NetherlandsSELECTBIOenquiries@selectbiosciences.com